CÁNCER DE MAMA
Hospital General Universitario de Alicante
Alicante, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital General Universitario de Alicante (9)
2021
2012
-
PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers
BMC Medical Genomics, Vol. 5
2010
-
Current controversies in the management of breast cancer
Clinical and Translational Oncology, Vol. 12, Núm. 4, pp. 278-286
-
Erratum: Current controversies in the management of breast cancer (Clinical and Translational Oncology 12:4 (278-286))
Clinical and Translational Oncology
2008
-
Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by paclitaxel for early breast cancer
Journal of the National Cancer Institute, Vol. 100, Núm. 11, pp. 805-814
2007
-
Advanced breast cancer: Chemotherapy phase III trials that change a standard
Anti-Cancer Drugs
-
Evidence-based use of taxanes in the adjuvant setting of breast cancer. A review of randomized phase III trials
Cancer Treatment Reviews, Vol. 33, Núm. 5, pp. 474-483
-
The use of taxanes in the neoadjuvant treatment of breast cancer: A review of randomized phase II/III trials
Clinical Breast Cancer, Vol. 7, Núm. 10, pp. 764-774